Editas Medicine Inc (NASDAQ:EDIT)

24.79
Delayed Data
As of Jul 22
 +0.94 / +3.94%
Today’s Change
17.80
Today|||52-Week Range
36.30
+8.97%
Year-to-Date

Today’s Trading

Previous close23.85
Today’s open23.92
Day’s range23.80 - 24.92
Volume572,943
Average volume (3 months)740,894
Market cap$1.2B
Data as of 4:00pm ET, 07/22/2019

Growth & Valuation

Earnings growth (last year)+21.66%
Earnings growth (this year)-8.82%
Earnings growth (next 5 years)-2.31%
Revenue growth (last year)+132.64%
P/E ratioNM
Price/Sales33.55
Price/Book4.93

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc+0.38+2.99%
XONIntrexon Corp+0.02+0.27%
RUBYRubius Therapeutics ...-0.43-2.85%
CRTXCortexyme Inc-0.01-0.02%
Data as of 4:00pm ET, 07/22/2019

Financials

Next reporting dateAugust 6, 2019
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$31.9M
Annual profit (last year)-$110.0M
Net profit margin-344.28%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Cynthia L. Collins
Interim Chief Financial &
Accounting Officer
Eric Ek
Corporate headquarters
Cambridge, Massachusetts

Forecasts